10:53 AM EST - Mind Cure Health Inc. : Announced the signing of a non-binding letter of intent for strategic investment and commercial cooperation with ATMA Journey Centers Inc., a Calgary-based organization. ATMA is the first commercial treatment center in Canada to announce providing psychedelic-assisted therapy for a section 56 exempt patient. The LOI is intended to help Mind Cure secure an equity position within ATMA, empowering the Company with access to a global release strategy for iSTRYM , as well as international locations for translational research on novel molecules and treatment protocols. Pursuant to the LOI, the parties intend to negotiate the terms of definitive agreements, which will provide for, among other things an initial $500,000 investment by Mind Cure in ATMA, participation by Mind Cure in ATMA's future financings, and the exclusive use of iSTRYM throughout ATMA's business. Mind Cure Health Inc.
shares C.MCUR are trading up 7.35 percent at $0.73.
